Table 2.
Between-group differences in outcomes.
| Outcome | Adjusted mean at baseline | Control versus YWDa, mean difference (95% CI) | P valueb | ||
|
|
|
2 months | 7 months | 12 months | |
| HbA1cc, mmol/mol | 78.9 | –2.8 (–5.4 to –0.3) | –6.2 (–9.5 to –2.9) | –4.3 (–8.0 to 0.7) | 0.02 |
| HbA1cc, % | 9.4 | –0.3 (–0.5 to 0.0) | –0.6 (–0.9 to –0.3) | –0.4 (–0.7 to 0.1) | 0.02 |
| PCDd scoree | 28.18 | 0.27 (–1.50 to 2.03) | –0.53 (–2.55 to 1.50) | –0.79 (–2.56 to 0.98) | 0.39 |
| PAIDf scoree | 23.68 | –2.64 (–6.17 to 0.88) | 0.96 (–3.00 to 4.91) | –3.14 (–7.22 to 0.95) | 0.13 |
| HCCQg scoree | 27.10 | –0.05 (–2.44 to 2.35) | 0.04 (–2.52 to 2.61) | –0.73 (–2.98 to 1.52) | 0.53 |
aYWD: Young with Diabetes.
bSignificance level of difference at 12 months follow-up.
cHbA1c: glycated hemoglobin.
dPCD: Perceived Competence in Diabetes Scale.
eRange for PCD and HCCQ is 5-35 and the range for PAID is 0-100.
fPAID: Problem Areas in Diabetes.
gHCCQ: Health Care Climate Questionnaire.